Ribon Therapeutics

Ribon Therapeutics is a Massachusetts-based biopharmaceutical company that researches and develops novel small molecule therapeutics for the treatment of cancer.

Business Model:

Revenue: $7M

Employees: 11-50

Detailed Ribon Therapeutics Information

Geographic Data

Ribon Therapeutics headquarters map

Address: 35 Cambridgepark Drive

City: Cambridge

State: MA

Zip: 02140

Country: US

Financial Info

Stage:

series c

Raised Last:

$65M

Raised Total:

$184M

Metrics

2,272,933Website Global Rank

8,362Website Monthly Traffic

Twitter Followers

Description

Ribon Therapeutics is a Massachusetts-based biopharmaceutical company that researches and develops novel small molecule therapeutics for the treatment of cancer.

Contact Phone:
+16179148700

Contact Email:

Announced Date Company Transaction Money Raised
Announced Date Transaction Number of Investors Money Raised Lead Investors
12/2015 Venture Round 3 $10M U.S. Venture Partners
The Column Group
OUP (Osage University Partners)
12/2022 Equity $25M Pfizer Venture Investments
Pfizer
1/2019 Series B 9 $65M Celgene
Deerfield Capital Management
Euclidean Capital
Johnson &a; Johnson Innovation – JJDC
Novartis Venture Fund
OUP (Osage University Partners)
Takeda Ventures
The Column Group
U.S. Venture Partners
Celgene
Deerfield Capital Management
Euclidean Capital
Johnson &a; Johnson Innovation – JJDC
Novartis Venture Fund
OUP (Osage University Partners)
Takeda Ventures
The Column Group
U.S. Venture Partners
5/2021 Equity $65M U.S. Venture Partners
The Column Group
Deerfield Management
Johnson & Johnson Development Corp.
Novartis Venture Fund
2/2016 Series A 5 $24M U.S. Venture Partners
The Column Group
OUP (Osage University Partners)
Euclidean Capital
Deepfield
10/2017 Venture Round $20M
6/2021 Series C $0 AbbVie Biotech Ventures
Avego Bioscience Capital
Bristol Myers Squibb
Deerfield
Euclidean Capital
GV
Johnson &a; Johnson Innovation – JJDC
Monashee Investment Management
Novartis Venture Fund
OUP (Osage University Partners)
Peregrine Ventures
Takeda Ventures
The Column Group
U.S. Venture Partners
AbbVie Biotech Ventures
Avego Bioscience Capital
Bristol Myers Squibb
Deerfield
Euclidean Capital
GV
Johnson &a; Johnson Innovation – JJDC
Monashee Investment Management
Novartis Venture Fund
OUP (Osage University Partners)
Peregrine Ventures
Takeda Ventures
The Column Group
U.S. Venture Partners
12/2022 Equity $25M
11/2015 Equity $23.5M Deerfield Management
U.S. Venture Partners
6/2021 Series C 14 $65M AbbVie Biotech Ventures
Avego Bioscience Capital
Bristol Myers Squibb
Deerfield
Euclidean Capital
GV
Johnson &a; Johnson Innovation – JJDC
Monashee Investment Management
Novartis Venture Fund
OUP (Osage University Partners)
Peregrine Ventures
Takeda Ventures
The Column Group
U.S. Venture Partners
AbbVie Biotech Ventures
Avego Bioscience Capital
Bristol Myers Squibb
Deerfield
Euclidean Capital
GV
Johnson &a; Johnson Innovation – JJDC
Monashee Investment Management
Novartis Venture Fund
OUP (Osage University Partners)
Peregrine Ventures
Takeda Ventures
The Column Group
U.S. Venture Partners
Announced Date Name Price

Employee Departments

Employee States

Uniview Singapore VEID Logo
Uniview Singapore VEID
Revenue: 0 - 100000
Employees:
Industry: Software
Details
Konkuk University Medical Center Logo
Konkuk University Medical Center
Revenue: 0 - 100000
Employees: 51 - 500
Industry: Education
Details
Daemon Technologies Logo
Daemon Technologies
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Blockchain
Details
Ace International Trade Logo
Ace International Trade
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Industrial
Details
An Hòa Communications Logo
An Hòa Communications
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Advertising
Details

You know, we could be doing all this for you..

CoBee's Logo

Be ahead of your competition

  • Realtime intelligence
  • Automated contact tracking
  • Unmatched insights
  • Eliminate manual research